Remedor Biomed
2009
FOUNDED
PRIVATE
STATUS
Accelerator/Inc
LATEST DEAL TYPE
1
INVESTORS
Description
Provider of a biomedical technology platform based on the combination of two naturally-occurring glycoproteints: erythropoietin (EPO) and fibronectin (FN). The company develops a formulation, based on erythropoietin and fibronectin, for therapeutical use in tissue regeneration in the processes of wound healing and bone repair.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Social/Platform Software
Primary Office
- Ha-Avoda Street 12
- Nazareth Iliit
- Israel
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Remedor Biomed’s full profile, request a free trial.
Remedor Biomed Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Remedor Biomed Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Next Generation Technology | Venture Capital | Minority | 000 0000 | 000000 0 |
Remedor Biomed Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Saher Remedor Ph.D | Founder, Chief Technology Officer & Chief Executive Officer |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »